Respiratory Syncytial Virus (RSV) can cause mild to severe respiratory illness, particularly in young children, older adults, and individuals with weakened immune systems. This RSV research study assesses the test vaccine’s clinical efficacy, safety, and reactogenicity in older adults.
RSV clinical trials are underway in Little River, South Carolina, to help find potential treatments for the condition.
Be a part of innovative research that could lead to life-saving treatments and improved healthcare for yourself and future generations.
Get the chance to try a new medication, device, or therapy before it’s widely available.
Deepen your understanding of your health condition and potentially experience direct benefits from the tested intervention.
Clinical trials are research studies that test the impact of new or existing medical interventions on human volunteers. These interventions can be anything from medications (think new drugs, vaccines, or therapies) to medical devices (pacemakers, stents, surgical techniques) and even treatment approaches (new surgical procedures, behavioral therapies). The entire process is meticulously designed to assess the intervention’s safety, effectiveness, dosage, and potential side effects.
